LDS/Medical Tests/Nexilin-like Protein (NEXN) Gene Mutation Analysis

Nexilin-like Protein (NEXN) Gene Mutation Analysis

The NEXN gene is located in the short (p) arm of chromosome 1 at position 31.1 and encode a cardiac Z-disc protein, nexilin. This protein has an essential role in the maintenance of the Z-disc, sarcomere integrity and it protects cardiac Z-discs from forces generated within the sarcomere. Mutation in NEXN gene destabilizes cardiac Z-disc and can cause both dilated cardiomyopathy and hypertrophic cardiomyopathy. Various pathogenic variants including missense, splicing, small /gross deletions have been identified in NEXN.

DCM is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Dilated cardiomyopathy (DCM) is most commonly inherited in an autosomal dominant or X-linked manner. DCM is the most common cause of congestive heart failure in young patients, although, conduction impairment, syncope and sudden death may also occur. It affects approximately 1 per 2,500 in the adult population. Many patients with dilated cardiomyopathy have no or only minor symptoms and live a normal life. Other individuals may develop symptoms such as fatigue, weight loss, fainting, palpitation, chest pain and sudden death. Inherited DCM can be categorized as acquired, syndromic, or non-syndromic depending on the causative mutation. Mutations in NEXN account for < 1% of inherited DCM.

Familial hypertrophic cardiomyopathy (HCM) is an inherited heart disorder characterized by unexplained left ventricular (LV) hypertrophy (thickening) associated with non-dilated ventricular chambers. HCM is diagnosed by identifying a left ventricular maximum wall thickness ≥15 mm in adults, ≥13 mm in a relative inherited from the family's pathogenic sarcomere variant, or a z-score >3 in children. Characteristic pathological features include myocardial fiber hypertrophy, disorganized myocardial cells, interstitial fibrosis and thickened intra-myocardial coronary vessels. The majority of HCM patients are asymptomatic. About 25% develop symptom such as dyspnea, syncope, collapse, palpitations, and chest pain. The disorder has inter- and intrafamilial variability ranging from benign cases to malignant forms with a high risk of cardiac failure and sudden cardiac death. HCM is typically inherited in an autosomal dominant manner. Familial hypertrophic cardiomyopathy affects an estimated 1 in 500 people worldwide. Mutations in NEXN account for < 1% of inherited HCM.

  • As an aid in diagnosis of familial hypertrophic cardiomyopathy and dilated cardiomyopathy
  • Carrier screening for relatives and those with the family history
  • Prenatal carrier screening for those with the family history
Mutation or pathogenic variant in NEXN gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative for mutations analyzed (No pathogenic variant or mutation detected)

Target sequencing by next generation sequencing (NGS), deletion/duplication analysis by quantitative multiplex PCR, long-range PCR, multiplex ligation dependent probe amplification (MLPA).

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Creatine kinase (CK), CK-MB, lactate dehydrogenase (LDH), troponin T, myosin light chain-1 (MLC-1), electrocardiogram, chest X-ray, exercise stress echocardiography, cardiac catheterization and magnetic resonance imaging (MRI).
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login